Myasthenia Gravis Foundation of America, Inc.

The MGFA Scientific Session provides neurologists and other physicians an opportunity to discuss their basic or clinical research on myasthenia gravis and other disorders of the neuromuscular junction. At this year’s session, held today, researchers presented 23 papers to a full house. Dr. Kevin O’Connor of Yale Department of Neurology gave the keynote address, "Mechanisms of Myasthenia Gravis Immunopathology." Another 114 posters are available to review during the American Association of Neuromuscular & Electrodiagnostic Medicine (AANEM) Annual Meeting this week in Savannah. Read the program on our website to learn more about paper and poster topics: https://lnkd.in/g-wZudWG Thank you to every researcher who makes a difference for the MG Community!

In this episode of Neurology Video Journal Club, Dr. Vera Bril of the University of Toronto is joined by Dr. Carolina Barnett-Tapia, also University of Toronto, to discuss an article published in the January 23, 2024 issue of Neurology: "Exploring Factors That Prolong the Diagnosis of Myasthenia Gravis." Watch their conversation to learn more about this important topic. https://ow.ly/ZFo050THkbG

Join us at the Houston MGFA Community Health Fair! Living with myasthenia gravis brings its challenges, but finding support and resources shouldn't be one of them. MGFA's FREE Community Health Fair is your gateway to a community that understands, supports, and empowers. The Houston Community Health Fair features MG lectures by several leading providers in partnership with Houston Methodist. Check out their website for more about the provider forum on Friday, October 11. 🗓 When: Saturday, October 12 | 9 AM - 2 PM 📍 Where: Houston Methodist Research Institute, Houston, TX *Connect & Share: Join others in the MG community to share experiences and find camaraderie. *Learn from Experts: Gain insights from medical professionals on managing MG with the latest treatments and strategies. *Access Resources: Explore educational and wellness resources tailored for you or your loved one. Thank you to our generous event sponsors, including National Presenting Sponsors Alexion Pharmaceuticals, Inc. and argenx. Register Today: https://lnkd.in/ezXpSjSJ

Reminder: Submit your abstract for the 15th Annual International Conference on Myasthenia and Related Disorders. Learn more at https://lnkd.in/eed2NDhu. #MyastheniaGravis #Neuromuscular #RareDiseaseConference

MGFA Scientific Session at AANEM is coming up soon. We look forward to seeing members of the neuromuscular community! Stay tuned, as we will share the most promising research papers and posters with you once they are presented. Subscribe to our Research News here: https://lnkd.in/eXVUE4Dn

In case you missed it, our Chief Medical Officer, Paul Peloso, M.D., led a webinar hosted by Myasthenia Gravis Foundation of America, Inc. He highlighted our #nanoparticle technology and provided an overview of our ongoing #ClinicalTrial in #MyastheniaGravis. Watch the recording to learn more: https://bit.ly/3XJO5JM

Learn more about research funded in part by the MGFA. Read about Dr. Ryan Hibbs' work on visualizations of the 3D structure of the muscle acetylcholine receptor. The findings of his recent co-authored study in Nature are already being applied to investigations of muscle-based disorders, such as congenital myasthenic syndromes (CMS). https://lnkd.in/duxutxcF

Join Dr. Mert Aral, Chief Medical Officer at Huma and Ben Irving, VP of AI at Huma, as they discuss how the HumaMG app can help people living with MG optimize their treatment and maintain symptom control. Discover the latest AI innovations poised to transform MG patient care by enhancing our understanding of impact of medication, improving symptom identification, and assisting clinicians in monitoring progress to optimize treatment. Register at https://lnkd.in/efa96_nJ.

MGFA Ambassador Greg Josephs shares his advice for other people living with #MyastheniaGravis in this new video from CheckRare: https://lnkd.in/eXKYvaA7

At Huma, we believe that AI is key to enabling personalised care at scale. Our HumaMG program uses advanced machine learning and imaging capabilities to support improved monitoring of disease progression for people with #MyastheniaGravis. On September 26, Huma's Chief Medical Officer Dr Mert Aral and Benjamin Irving, VP ML & Imaging, will be leading a webinar session hosted by the Myasthenia Gravis Foundation of America, Inc., in which they'll share more on the HumaMG app and how it uses AI to enhance the #MG care pathway. Living Better with MG: How AI Enhances Treatment and Management 📅 Date: Thursday, September 26, 12pm EST 🔗 Register here:https://lnkd.in/efa96_nJ 🔗 Learn more about HumaMG: https://lnkd.in/eekJTUxQ